Raleigh, NC, United States of America

Peter Vu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: United Therapeutics Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Vu. Retrieved from https://idiyas.com/inventor/peter-vu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peter Vu: Advancing Endothelial Cell Barrier Research

Introduction

Peter Vu is an inventor based in Raleigh, North Carolina, and is associated with United Therapeutics Corporation. His patent work focuses on methods and compositions intended to improve the vascular barrier formed by endothelial cells.

Latest Patents

Vu is named on 1 patent, titled “Methods and Compositions for Improving Endothelial Cell Barrier.” The patent describes approaches for strengthening endothelial cell barriers using barrier agonist compounds and improved cell-culturing techniques. These approaches may involve an adenylyl cyclase activator, an activator of Sphingosine-1-phosphate receptor internalization, or agents that directly or indirectly induce tight junction or adherens junction protein expression.

Career Highlights

Vu’s listed invention addresses endothelial cell culture and vascular barrier function, areas relevant to research into maintaining the integrity of blood vessels. His work is associated with United Therapeutics Corporation.

Collaborations

Among Vu’s listed coworkers are Bryan Fioret and Thomas Petersen. Their shared professional context is associated with United Therapeutics Corporation.

Conclusion

Peter Vu’s patent highlights methods and compositions for improving endothelial cell barriers through targeted compounds and enhanced cell-culturing techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…